This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Momenta Pharmaceuticals next reports earnings on May 06, 2014.
To receive a free e-mail notification whenever Momenta Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
<br/> - Feb. 27, 2015
Momenta Pharmaceuticals Just Filed Its Annual Report: Net Loss Per Comm... - Feb. 27, 2015
Prospectus [Rule 424(b)(5)] - Feb. 27, 2015
Senior VP of Momenta Pharmaceuticals just disposed of 64 shares - Feb. 26, 2015
SVP of Momenta Pharmaceuticals just disposed of 192 shares - Feb. 25, 2015